CoChat

Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle Cells

Open access
Work, Lorraine M, Nicklin, Stuart A, Brain, Nick J.R, Dishart, Kate L, Von Seggern, Dan J, Hallek, Michael, Büning, Hildegard, Baker, Andrew H · 2004 · Molecular Therapy
Cited by 115

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The vascular smooth muscle cell (SMC) is integral to the pathogenesis of neointimal formation associated with late vein graft failure, in-stent restenosis, and transplant arteriopathy. Viral vectors transduce SMC with low efficiency and hence, there is a need for improvement. We aimed to enhance the efficiency and selectivity of gene delivery to human SMC. Targeting ligands were identified using phage display on primary human saphenous vein SMC with linear and cyclic libraries. Two linear peptides, EYHHYNK (EYH) and GETRAPL (GET), were incorporated into the HI loop of adenovirus (Ad) fibers and the capsid protein of adeno-associated virus-2 (AAV-2). Exposure of human venous SMC to EYH-modified (but not the GET-modified) Ad vector resulted in a significant increase in transgene expression levels at short, clinically relevant exposure times. Similarly, the EYH-modified AAV vector resulted in enhanced gene transfer to human venous SMC but not endothelial cells in a time- and dose-dependent manner. The EYH-modified AAV vector also enhanced (up to 70-fold) gene delivery to primary human arterial SMC. Hence, incorporation of EYH into Ad and AAV capsids resulted in a significant and selective enhancement in transduction of SMC and has implications for improving local gene delivery to the vasculature.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2003.11.006

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 115

Metadata

Authors
Work, L. M., Nicklin, S. A., Brain, N. J. R., Dishart, K. L., Von Seggern, D. J., Hallek, M., Büning, H., & Baker, A. H.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2004-02
Volume
9
Issue
2
Pages
198-208
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2057955115
Cited by
115
References
2
FWCI
4.19
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle Cells. https://app.cochat.ai/papers/10.1016/j.ymthe.2003.11.006
The paper
Work, L. M., Nicklin, S. A., Brain, N. J. R., Dishart, K. L., Von Seggern, D. J., Hallek, M., Büning, H., & Baker, A. H. (2004). Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle Cells. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2003.11.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.